Highly concentrated low viscosity MASP-2 inhibitory antibody preparations, kits, and methods of treating subjects suffering from atypical hemolytic syndrome

摘要

The present invention relates to a treatment method using a stable high concentration low viscosity formulation of a MASP-2 inhibitory antibody for treating a subject suffering from atypical hemolytic uremic syndrome (aHUS), a kit comprising the formulation.